RiverVest invites you to read our latest newsletter, featuring:
- 2025 Annual Meeting Recap
- RiverVest Portfolio: Year in Review
- The Sugar Fix: A New Approach to Treating a Rare Glycosylation Disorder
- Portfolio News
RIVERVEST NEWSLETTER
June 2025 Issue
RiverVest News features insights and updates on the Science, Strategy, and Innovation behind our investments.
→ Subscribe to our newsletter (delivered to your email inbox three times per year)
→ Read Past Issues of RiverVest News (Newsletter Archive)
RiverVest Venture Partners is a leading venture capital firm building life science companies to address significant unmet needs of patients and deliver consistently strong returns to investors. With headquarters in St. Louis and offices in San Diego and Cleveland, RiverVest accesses forward-thinking research and clinical expertise at leading institutions across the country to found and fund biopharma and medical device companies.
Paragraph